Steris (STE) Dividends Paid - Common Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.02% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.31% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.56% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12,260.00% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -1.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,260.00% |
| Dec 31, 2025 | -9.99% |
| Sep 30, 2025 | 9.95% |
| Jun 30, 2025 | 9.34% |
| Mar 31, 2025 | 247.87% |
| Dec 31, 2024 | -306.51% |
| Sep 30, 2024 | 9.60% |
| Jun 30, 2024 | 10.71% |
| Mar 31, 2024 | -8.46% |
| Dec 31, 2023 | 9.51% |
| Sep 30, 2023 | 9.36% |
| Jun 30, 2023 | 7.95% |
| Mar 31, 2023 | -416.15% |
| Dec 31, 2022 | 9.08% |
| Sep 30, 2022 | 9.34% |
| Jun 30, 2022 | 25.95% |
| Mar 31, 2022 | 1,112.02% |
| Dec 31, 2021 | 166.24% |
| Sep 30, 2021 | 26.02% |
| Jun 30, 2021 | 8.51% |
| Mar 31, 2021 | 103.93% |
| Dec 31, 2020 | -306.96% |
| Sep 30, 2020 | 8.57% |
| Jun 30, 2020 | 9.19% |
| Dec 31, 2019 | 157.31% |
| Sep 30, 2019 | 9.24% |
| Jun 30, 2019 | 9.74% |